Matches in Nanopublications for { ?s ?p "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.
- _3 value "(From full text) Figure 3. Identification of E2F1 and E2F4 binding sites on human promoters (p<0.01). " provenance.